The decline in the reported number of new transmissions of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections across European Union (EU) and European Economic Area (EEA) countries has continued.
The purpose of this scoping review is to describe and summarise the rationale behind and methodological approaches used to conduct cascade-of-care analyses for TB infection in low-TB incidence countries.
The United Nations has set a goal to end the tuberculosis epidemic by 2030 but despite an overall downward trend of TB cases in Europe, the current decline in the number of cases will not be sufficient to meet these targets.
Tuberculosis remains a global health threat, affecting millions worldwide and claiming too many lives each year. The timely strengthening of prevention, testing and treatment are key elements in fighting TB.
Nearly 7,000 excess deaths from tuberculosis occurred in the WHO European Region in the three years of the pandemic from 2020 - 2022, compared to what experts had expected based on pre-2020 estimates.
This joint guidance by the ECDC and EMCDDA aims to strengthen the evidence base for developing national strategies for preventing and controlling infections and infectious diseases among people who inject drugs.